Intracranial Aneurysm
SKU
MRR-A339DAEF9EC7
Region
Global
Publication Date
February 2024
Delivery
Immediate
2022
USD 1.09 billion
2030
USD 5.38 billion
2023
USD 1.32 billion
CAGR
21.98%
Intracranial Aneurysm Market by Type (Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters), Indication (Ruptured Aneurysm, Unruptured Aneurysm), End User - Global Forecast 2023-2030

[185 Pages Report] The Intracranial Aneurysm Market size was estimated at USD 1.09 billion in 2022 and expected to reach USD 1.32 billion in 2023, at a CAGR 21.98% to reach USD 5.38 billion by 2030.

Intracranial Aneurysm Market
To learn more about this report, request a free sample copy

The intracranial aneurysm market is the healthcare industry sector focused on diagnosing, treating, and managing intracranial aneurysms, bulges, or ballooning in the walls of arteries within the cranium. The market includes various products and services such as diagnostic equipment, surgical tools, medications, and a wide range of treatment options, including surgical and non-surgical interventions. Growth in the intracranial aneurysm market is influenced by factors such as the aging global population, the increasing prevalence of hypertension and smoking, advancements in medical imaging technologies, and the rise in public awareness about the condition. Additionally, improvements in healthcare infrastructure, increased healthcare spending, and the growing demand for minimally invasive surgeries contribute to market expansion. Limitations affecting the intracranial aneurysm market growth include high treatment costs, limited access to healthcare facilities in underdeveloped and developing regions, and the risks associated with invasive surgical procedures. Along with these, stringent regulatory frameworks governing product approval and the need for skilled professionals capable of performing specialized interventions. However, the market witnessed new potential opportunities, including developing more effective and less invasive treatment techniques, applying artificial intelligence for enhanced imaging and diagnostics, and introducing novel biomaterials for stents and coils used in endovascular treatments. Furthermore, advancements in genetic research could lead to early detection and personalized treatment strategies.

Intracranial Aneurysm Market - Global Forecast 2023-2030
To learn more about this report, request a free sample copy
Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms

Artery occlusion and bypass procedures are surgical interventions utilized when an intracranial aneurysm is considered too difficult or dangerous to treat with less invasive methods. These procedures involve closing off the affected artery and rerouting the blood flow using a vessel graft to preserve cerebral circulation. This technique is typically reserved for complex aneurysms that are not amenable to endovascular techniques or where previous treatments have failed. Endovascular coiling is a minimally invasive procedure that implicates inserting a catheter into an artery and navigating it to the aneurysm site. Soft metal coils are then deployed through the catheter into the aneurysm, promoting blood clotting and preventing blood flow into the aneurysm, thus reducing the risk of rupture. Endovascular coiling is often the preferred choice for treating many intracranial aneurysms due to its less invasive nature and reduced recovery time compared to open surgery. Flow diverters are endovascular devices designed to treat large and giant aneurysms and those with a wide base that is not suitable for coiling. These stent-like devices are placed across the neck of the aneurysm to redirect blood flow away from the aneurysm sac. Over time, this leads to thrombosis within the aneurysm and reconstruction of the affected vessel segment. Flow diverters are effective in occluding aneurysms while preserving blood flow in the parent artery. Surgical clipping is a traditional and definitive treatment for intracranial aneurysms that involves a craniotomy to expose the aneurysm. A neurosurgeon then places a small metal clip at the base of the aneurysm, effectively isolating it from the arterial blood flow. This prevents the aneurysm from growing or rupturing. While the procedure is invasive and requires a longer recovery period, it is a durable solution with a high long-term success rate.

End User: Rising patient flow across clinics for early screening and diagnostic services

Clinics, particularly those specializing in neurology and radiology, provide services for diagnosing and treating intracranial aneurysms. These facilities are usually smaller than hospitals and are often preferred by patients for early diagnosis, outpatient care, and convenience. Hospitals represent the most comprehensive end-use segment for intracranial aneurysm management, offering a full spectrum of diagnostic, surgical, and postoperative care. They are typically equipped with advanced neuroimaging technologies, such as high-resolution MRI and CT scanners, essential for the precise diagnosis and preoperative planning of aneurysm treatment. Hospitals facilitate open surgical procedures, such as microsurgical clipping, and endovascular therapies, such as coiling or flow diversion, conducted in well-equipped operating theaters with trained neuro-interventional radiologists and neurosurgeons. Post-treatment, hospitals provide intensive care units for monitoring patients, particularly after invasive surgeries or in the event of complications such as aneurysm rupture.

Regional Insights

In the Americas, the prevalence of intracranial aneurysms is influenced by a combination of genetic, environmental, and lifestyle factors. There is a substantial investment in healthcare infrastructure and research into neurological disorders, including intracranial aneurysms. The U.S. and Canada have advanced healthcare systems with high diagnosis and treatment rates, including surgical interventions and minimally invasive procedures. In the EMEA region, Europe has significant research and management of intracranial aneurysms, with many countries adopting modern endovascular treatments such as coiling and flow diversion. The Middle East has seen growth in healthcare infrastructure with the increasing availability of neurointerventional facilities. However, there are variations in prevalence and management approaches due to diverse socioeconomic and healthcare systems across the EMEA. Africa faces challenges due to limited healthcare resources, but there is ongoing progress in major urban centers. The Asia-Pacific region presents a varied landscape for intracranial aneurysms. Countries including Japan and South Korea have high technological adoption rates and a strong focus on innovation in medical treatments. Countries such as China and India are rapidly developing their healthcare infrastructure, improving access to neurovascular care.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intracranial Aneurysm Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intracranial Aneurysm Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Evasc announces clinical milestones and plans to expand European presence with German subsidiary

    Evasc Neurovascular expanded its business in Europe by inaugurating a new subsidiary, Evasc Neurovascular GmbH, in Germany. This strategic decision marks a major advancement in Evasc's mission to enhance neurovascular care in the European region, promising more efficient services and bolstering its direct sales operations. Furthermore, Evasc underscores its commitment to innovation and patient care with developments in the France-based EESIS trial, underpinning the effectiveness and safety of its pioneering neurovascular solutions. [Published On: 2024-01-05]

  • OU Researchers Designing Device to Improve Brain Aneurysm Treatment

    University of Oklahoma professor launched a project to design a device that can improve brain aneurysm treatment. With a keen emphasis on subarachnoid hemorrhages and acute bleedings that occur in the space between the brain and its protective membrane, typically triggered by the rupture of an aneurysm, this project aims to devise a customizable medical device. This innovation seeks to enhance patient-specific care for these potentially fatal cerebrovascular irregularities. The research addresses the limitations of the current treatment modalities, which include the highly invasive surgical clip ligation, entailing an open-skull operation, and the less invasive but widely adopted endovascular coil embolization, a procedure that employs a catheter to place soft coils and prevent blood from entering the aneurysm. [Published On: 2023-09-21]

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abbvie Inc., Acandis GmbH, Adeor Medical AG, B. Braun Melsungen AG, Balt Extrusion S.A., Bayer AG, Bristol-Myers Squibb Company, Cardiatis, S.A., Evasc Medical Systems Corp, F. Hoffmann-La Roche AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corporation, Medtronic PLC, Merck & Co., Inc., Microport Scientific Corporation, Mizuho Medical Co,Ltd., Oxford Endovascular Ltd., Penumbra, Inc., Pfizer Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Artery Occlusion & Bypass
    • Endovascular Coiling
    • Flow Diverters
    • Surgical Clipping
  • Indication
    • Ruptured Aneurysm
    • Unruptured Aneurysm
  • End User
    • Clinics
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Intracranial Aneurysm Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intracranial Aneurysm Market?
  3. What are the technology trends and regulatory frameworks in the Intracranial Aneurysm Market?
  4. What is the market share of the leading vendors in the Intracranial Aneurysm Market?
  5. Which modes and strategic moves are suitable for entering the Intracranial Aneurysm Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageINTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. INTRACRANIAL ANEURYSM MARKET SIZE, 2022 VS 2030
  4. Market Overview
    1. IntroductionINTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
    2. Intracranial Aneurysm Market, by RegionINTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2022 VS 2030 (%)INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsINTRACRANIAL ANEURYSM MARKET DYNAMICS
      1. Drivers
        1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
        2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
        3. Improved Diagnosis for Intracranial Aneurysm
      2. Restraints
        1. Side Effects Associated with Therapies and High Cost of Treatments
      3. Opportunities
        1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
        2. Rising Potential for Endovascular Coiling
      4. Challenges
        1. Issues Related to Timing of Surgery and Anesthetic Induction
    2. Market Segmentation Analysis
      1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
      2. End User: Rising patient flow across clinics for early screening and diagnostic services
    3. Market Trend Analysis
    4. Cumulative Impact of COVID-19
    5. Cumulative Impact of Russia-Ukraine Conflict
    6. Cumulative Impact of High Inflation
    7. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    8. Value Chain & Critical Path Analysis
    9. Regulatory Framework
    10. Client Customization
  6. Intracranial Aneurysm Market, by Type
    1. IntroductionINTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2022 VS 2030 (%)INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
    2. Artery Occlusion & BypassINTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY , 2018-2030 (USD MILLION)
    3. Endovascular CoilingINTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY , 2018-2030 (USD MILLION)
    4. Flow DivertersINTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY , 2018-2030 (USD MILLION)
    5. Surgical ClippingINTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY , 2018-2030 (USD MILLION)
  7. Intracranial Aneurysm Market, by Indication
    1. IntroductionINTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
    2. Ruptured AneurysmINTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY , 2018-2030 (USD MILLION)
    3. Unruptured AneurysmINTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY , 2018-2030 (USD MILLION)
  8. Intracranial Aneurysm Market, by End User
    1. IntroductionINTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2022 VS 2030 (%)INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    2. ClinicsINTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY , 2018-2030 (USD MILLION)
    3. HospitalsINTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY , 2018-2030 (USD MILLION)
  9. Americas Intracranial Aneurysm Market
    1. Introduction
    2. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2022 VS 2030 (%)UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Intracranial Aneurysm Market
    1. Introduction
    2. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Intracranial Aneurysm Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixINTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2022INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2022
    2. Market Share Analysis, By Key PlayerINTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2022INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2022
    3. Competitive Scenario Analysis, By Key Player
      1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
      2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment
  13. Competitive Portfolio
    1. Key Company Profiles
      1. Abbott Laboratories
      2. Abbvie Inc.
      3. Acandis GmbH
      4. Adeor Medical AG
      5. B. Braun Melsungen AG
      6. Balt Extrusion S.A.
      7. Bayer AG
      8. Bristol-Myers Squibb Company
      9. Cardiatis, S.A.
      10. Evasc Medical Systems Corp
      11. F. Hoffmann-La Roche AG
      12. Integra Lifesciences Holdings Corporation
      13. Johnson & Johnson Services, Inc.
      14. Kaneka Corporation
      15. Medtronic PLC
      16. Merck & Co., Inc.
      17. Microport Scientific Corporation
      18. Mizuho Medical Co,Ltd.
      19. Oxford Endovascular Ltd.
      20. Penumbra, Inc.
      21. Pfizer Inc.
      22. Stryker Corporation
      23. Terumo Corporation
    2. Key Product Portfolio
  1. Abbott Laboratories
  2. Abbvie Inc.
  3. Acandis GmbH
  4. Adeor Medical AG
  5. B. Braun Melsungen AG
  6. Balt Extrusion S.A.
  7. Bayer AG
  8. Bristol-Myers Squibb Company
  9. Cardiatis, S.A.
  10. Evasc Medical Systems Corp
  11. F. Hoffmann-La Roche AG
  12. Integra Lifesciences Holdings Corporation
  13. Johnson & Johnson Services, Inc.
  14. Kaneka Corporation
  15. Medtronic PLC
  16. Merck & Co., Inc.
  17. Microport Scientific Corporation
  18. Mizuho Medical Co,Ltd.
  19. Oxford Endovascular Ltd.
  20. Penumbra, Inc.
  21. Pfizer Inc.
  22. Stryker Corporation
  23. Terumo Corporation
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Intracranial Aneurysm Market
The Global Intracranial Aneurysm Market size was estimated at USD 1.09 billion in 2022 and expected to reach USD 1.32 billion in 2023.
The Global Intracranial Aneurysm Market to grow USD 5.38 billion by 2030, at a CAGR of 21.98%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.